[1]
Seddiki S. M. L., University Center of Naâma, Institute of Sciences, Dept. of nature and life sciences, Naâma, Algeria; Laboratory of Antibiotic and Antifungal: Physico-Chemistry, Synthesis and Biological Activity, Department of Biology, Faculty of Natural Science and Life, University of Tlemcen, Tlemcen, Algeria.
[2]
Boucherit-Otmani Z., Laboratory of Antibiotic and Antifungal: Physico-Chemistry, Synthesis and Biological Activity, Department of Biology, Faculty of Natural Science and Life, University of Tlemcen, Tlemcen, Algeria.
[3]
Kunkel D., Dennis Kunkel Microscopy Inc, Kailua, HI, USA.
[1]
Leonidia L and Charalambos AG, 2010. Catheter-related bloodstream infections: catheter management according to pathogen. International Journal of Antimicrobial Agents 36S S26-S32.
[2]
Pfaller M. A., Diekema D. J., Jones R. N., Sader H. S., Fluit A. C., Hollis R. J., Messer S. A. and The SENTRY Participant Group, 2001 International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in-vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. Journal of Clinical Microbiology 39: 3254-3259.
[3]
Boo TW, O’Reilly B, O’Leary J and Cryan B, 2005. Candidaemia in an lrish tertiary referral hospital: Epidemiology and prognostic factors. Mycoses 48: 251-259.
[4]
Kibbler C, 2007. Evolution de l’épidémiologie des candidoses et aspergilloses invasives. Médecine et maladies infectieuses 37: 2-4.
[5]
Seddiki SML, Boucherit-Otmani Z, Bettioui RA, Boucherit K, Taleb M and Kunkel D, 2015. Nosocomial Fungal Infectivities: In Vivo Formation of Candida Biofilms on Catheters Surfaces. American Journal of Microbiology and Biotechnology 2: 38-43.
[6]
Kojic EM and Darouiche RO, 2004. Candida infections of medical devices. Clinical Microbiology Reviews 17: 255-267.
[7]
Hot A, Mittaine B and Dupont B, 2007. Infections fongiques invasives du grand prématuré. Journal de Mycologie Medicale 17: 33-41.
[8]
Adam B., Baillie GS and Douglas LJ, 2002. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. Journal of Medical Microbiology 51: 344-349.
[9]
Harriott MM and Noverr MC, 2010. Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation. Antimicrobial Agents and Chemotherapy 54: 3746-3755.
[10]
Vale-Silva LA and Sanglard D, 2015. Tipping the balance both ways: drug resistance and virulence in Candida glabrata. FEMS Yeast Research 15: 1-8.
[11]
Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S and Rapin M, 1987. Diagnosis of central venous catheter-related sepsis: critical level of quantitative tip cultures. Archives Of Internal Medicine147: 873-877.
[12]
O'Toole G. A, 2011. Microtiter Dish Biofilm Formation Assay. Journal of Visualized Experiments 47: 2437.
[13]
Chandra J, Mukherjee PK and Ghannoum MA, 2008 In vitro growth and analysis of Candida biofilms. Nature Protocols 3: 1909-1924.
[14]
Theaker C, 2005 Infection control issues in central venous catheter care. Intensive and Critical Care Nursing 21: 99-109.
[15]
Ramage G, Mowat E, Jones B, Williams C and Lopez-Ribot J, 2009 Our Current Understanding of Fungal Biofilms. Critical Reviews in Microbiology 35: 340–355.
[16]
Perumal P, Mekala S and Chaffin WL, 2007 Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms. Antimicrobial Agents and Chemotherapy 51: 2454-2463.
[17]
Thein ZM, Seneviratne CJ, Samaranayake YH and Samaranayake LP, 2009. Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses 52: 467-475.
